Biomimetic Membrane Vesicles Reprogram Microglia Polarization and Remodel the Immunosuppressive Microenvironment of Glioblastoma via PERK/HIF‐1α/Glycolysis Pathway
Advanced Healthcare Materials · 2025
DOI: 10.1002/adhm.202404782 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Yinghan Guo und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China. Hauptthemen laut MEDLINE: Glioblastoma, Microglia, Hypoxia-Inducible Factor 1, alpha Subunit, Glycolysis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key R&D Program of Zhejiang.
Abstract (Originalsprache)
The malignant interaction between tumor cells and immune cells is one of the important reasons for the rapid progression and refractoriness of glioblastoma (GBM). As an essential metabolic center of M2 macrophages, the inhibition of protein kinase RNA‐like endoplasmic reticulum kinase (PERK) leads to the reduction of M2 macrophages. Nevertheless, the restriction of the blood‐brain barrier (BBB) and non‐specific cell targeting hinder the application of PERK inhibitors in GBM. Herein, the optimal NP‐M‐M2pep is developed successfully, which has shown the capacity of BBB penetration and specific targeting of M2 microglia. In addition to inhibiting the polarization of M2 microglia, the administration of iPERK@NP‐M‐M2pep reprogrammed M2 microglia into M1 ones in vitro via PERK/HIF‐1α/glycolysis pathway. Efficient brain accumulation of nanoparticles is achieved after tail vein injection, with effective inhibition of GBM progression after one course of treatment. The glioma‐associated microglia and macrophages (GAM) with M2 type are induced to M1 and the immunosuppressive TME is remodeled by upregulating immunostimulatory cells and downregulating immunosuppressive cells. In summary, the biomimetic membrane vesicles (BMVs) specifically delivered iPERK to GAMs offer an inspiring strategy to reprogram microglia polarization, re‐educate immunosuppressive TME, and inhibit the progression of GBM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, the Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, Zhejiang, 310009, China.
- Zhejiang Key Laboratory of Research and Transformation for Major Neurosurgical Diseases, Hangzhou, Zhejiang, 310009, China.
- MOE Key Laboratory of Macromolecular Synthesis and Functionalization, Department of Polymer Science and Engineering, Zhejiang University, Hangzhou, 310027, China.
- Department of Neurosurgery, affiliated Jinhua Hospital, School of Medicine, Zhejiang University, Jinhua, Zhejiang, 321000, China.
ORCID-Profile: Zhengwei Mao
Förderung
- National Natural Science Foundation of China
- Key R&D Program of Zhejiang
Zitieren
APA
Guo, Y., Jin, L., Shen, Z., Fan, L., Yu, X., Kuang, Y., Cai, L., Zhou, J., Chen, Z., Yan, F., Zhang, J., Tong, M., Yuan, J., Mao, Z., & Chen, G. (2025). Biomimetic Membrane Vesicles Reprogram Microglia Polarization and Remodel the Immunosuppressive Microenvironment of Glioblastoma via PERK/HIF‐1α/Glycolysis Pathway. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202404782
Vancouver
Guo Y, Jin L, Shen Z, Fan L, Yu X, Kuang Y, et al. Biomimetic Membrane Vesicles Reprogram Microglia Polarization and Remodel the Immunosuppressive Microenvironment of Glioblastoma via PERK/HIF‐1α/Glycolysis Pathway. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202404782
BibTeX
@article{Guo2025,
author = {Guo, Yinghan and Jin, Lulu and Shen, Zhipeng and Fan, Linfeng and Yu, Xian and Kuang, Yirui and Cai, Lingxin and Zhou, Jiayin and Chen, Zihang and Yan, Feng and Zhang, Jianmin and Tong, Minfeng and Yuan, Jianlie and Mao, Zhengwei and Chen, Gao},
title = {Biomimetic Membrane Vesicles Reprogram Microglia Polarization and Remodel the Immunosuppressive Microenvironment of Glioblastoma via PERK/HIF‐1α/Glycolysis Pathway},
journal = {Advanced Healthcare Materials},
year = {2025},
doi = {10.1002/adhm.202404782}
}
EUVIMED